Phase
Condition
Parkinson's Disease
Alzheimer's Disease
Lewy Body Dementia
Treatment
N/AClinical Study ID
Ages 55-90 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Subjects must be adults between 55 to 90 years of age with an established diagnosisfor dementia in accordance with DSM-IV criteria and have to fulfil at least one of thefollowing: The ICC criteria for probable and possible DLB, the National Institute ofNeurological and Communicative Disorders and Stroke and Alzheimer Disease and RelatedDisorders Association (NINCDS-ADRDA) for Alzheimer’s Disease (AD), or the NationalInstitute of Neurological and Communicative Disorders and Association InternationalePour la Recherche et l’Enseignement en Neurosciences (NINCS-AIREN) for VascularDementia (VaD).
Exclusion
Exclusion Criteria:
Subjects are not eligible if they have a Mini Mental State Examination (MMSE) score of <10 and use medication known or suspected to interact with the striatal uptake DaTSCANto the dopamine transporter.
Furthermore subjects are not eligible if they were diagnosed with idiopathicParkinson’s Disease (PD), with persistent severe depression, normal pressurehydrocephalus, multiple system atrophy, cortico-basal degeneration or Huntington’sChorea Disease.
Study Design
Study Description
Connect with a study center
Amersham Buchler GmbH Co. KG
Ismaning,
GermanySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.